Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a diabetes drug fix tiny blood vessels? new trial halted

NCT ID NCT05478707

First seen Jan 05, 2026 · Last updated May 24, 2026 · Updated 24 times

Summary

This study aimed to see if dulaglutide, a drug that helps control blood sugar, could also improve the function of small blood vessels in adults with type 1 diabetes. The trial planned to enroll 47 people aged 18-40 with type 1 diabetes for over 5 years. The study is currently suspended, so no results are available yet.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOTHELIAL DYSFUNCTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of Virginia

    Charlottesville, Virginia, 22908, United States

Conditions

Explore the condition pages connected to this study.